| Clinical Study "Common" Name (formal title) | Number of enrollees | Funding source (pharma/NIH) | Year complete | Primary publication | Full study treatment protocol |
|---|---|---|---|---|---|
| SCORE2 (Study of COmparative Treatments for REtinal Vein Occlusion 2) | 362 | National Eye Institute/NIH; Research to Prevent Blindness | 2017 |
Scott IU, VanVeldhuisen PC, Ip MS, et al. SCORE2 report 2: study design and baseline characteristics.Ophthalmology. 2017;124(2):245-256. https://www.aaojournal.org/article/S0161-6420(16)30902-2/fulltext |
 |